Long‐acting beta2‐agonists for poorly reversible chronic obstructive pulmonary disease

S Appleton, P Poole, BJ Smith, A Veale… - Cochrane database …, 2006 - cochranelibrary.com
Background Chronic obstructive pulmonary disease (COPD) is characterised by partially
reversible airflow limitation. Many patients have little reversibility to short acting …

The clinical importance of dynamic lung hyperinflation in COPD

DE O'Donnell, P Laveneziana - COPD: Journal of Chronic …, 2006 - Taylor & Francis
Lung hyperinflation commonly accompanies expiratory flow-limitation in patients with
Chronic Obstructive Pulmonary Disease (COPD) and contributes importantly to dyspnea and …

Interpretative strategies for lung function tests

R Pellegrino, G Viegi, V Brusasco… - European respiratory …, 2005 - Eur Respiratory Soc
BACKGROUND This section is written to provide guidance in interpreting pulmonary
function tests (PFTs) to medical directors of hospital-based laboratories that perform PFTs …

Espirometría

F García-Río, M Calle, F Burgos, P Casan… - Archivos de …, 2013 - Elsevier
Spirometry is the main pulmonary function test and is essential for the evaluation and
monitoring of respiratory diseases. Its utility transcends the field of Respiratory Medicine, is …

Incorporating the patient's perspective into drug development and communication: an ad hoc task force report of the Patient‐Reported Outcomes (PRO) Harmonization …

C Acquadro, R Berzon, D Dubois, NK Leidy… - Value in …, 2003 - Wiley Online Library
Background: The extent to which patient‐based outcomes can be used to evaluate and
communicate the effect of new drugs and devices is a subject of much debate. Criteria for …

Improvement in resting inspiratory capacity and hyperinflation with tiotropium in COPD patients with increased static lung volumes

B Celli, R ZuWallack, S Wang, S Kesten - Chest, 2003 - Elsevier
Background In patients with COPD, changes in inspiratory capacity (IC) have shown a
higher correlation to patient-focused outcomes, such as dyspnea with exercise, than other …

Salmeterol plus theophylline combination therapy in the treatment of COPD

RL ZuWallack, DA Mahler, D Reilly, N Church… - Chest, 2001 - Elsevier
Background Patients with COPD often require multiple therapies to improve lung function
and decrease symptoms and exacerbations. Salmeterol and theophylline are indicated for …

[HTML][HTML] Mechanisms, assessment and therapeutic implications of lung hyperinflation in COPD

A Rossi, Z Aisanov, S Avdeev, G Di Maria… - Respiratory …, 2015 - Elsevier
The main complaint of patients with chronic obstructive pulmonary disease (COPD) is
shortness of breath with exercise, that is usually progressive. The principal mechanism that …

Ipratropium bromide versus long‐acting beta‐2 agonists for stable chronic obstructive pulmonary disease

S Appleton, T Jones, P Poole… - Cochrane Database …, 1996 - cochranelibrary.com
Background Chronic obstructive pulmonary disease (COPD) is a condition associated with
high morbidity, mortality and cost to the community. Patients often report symptomatic …

Lung hyperinflation in COPD: applying physiology to clinical practice

DE O'Donnell, KA Webb, JA Neder - COPD Research and Practice, 2015 - Springer
In chronic obstructive pulmonary disease (COPD), worsening expiratory flow limitation
together with alteration in the elastic properties of the lung are associated with progressive …